Community-acquired pneumonia guidelines: a global perspective.
Identifieur interne : 000454 ( Main/Exploration ); précédent : 000453; suivant : 000455Community-acquired pneumonia guidelines: a global perspective.
Auteurs : Michael S. Niederman [États-Unis] ; Carlos M. LunaSource :
- Seminars in respiratory and critical care medicine [ 1098-9048 ] ; 2012.
Descripteurs français
- KwdFr :
- Antibactériens (usage thérapeutique), Canada, Europe, Géographie, Humains, Indice de gravité médicale, Infections communautaires (), Infections communautaires (microbiologie), Infections à staphylocoques (), Pneumonie à pneumocoques (), Pneumopathie infectieuse (), Pneumopathie infectieuse (microbiologie), Recommandations comme sujet, Santé mondiale, Staphylococcus aureus résistant à la méticilline, États-Unis d'Amérique.
- MESH :
- microbiologie : Infections communautaires, Pneumopathie infectieuse.
- usage thérapeutique : Antibactériens.
- Canada, Europe, Géographie, Humains, Indice de gravité médicale, Infections communautaires, Infections à staphylocoques, Pneumonie à pneumocoques, Pneumopathie infectieuse, Recommandations comme sujet, Santé mondiale, Staphylococcus aureus résistant à la méticilline, États-Unis d'Amérique.
- Wicri :
- geographic : Canada, États-Unis.
English descriptors
- KwdEn :
- Anti-Bacterial Agents (therapeutic use), Canada, Community-Acquired Infections (microbiology), Community-Acquired Infections (therapy), Europe, Geography, Global Health, Guidelines as Topic, Humans, Methicillin-Resistant Staphylococcus aureus, Pneumonia (microbiology), Pneumonia (therapy), Pneumonia, Pneumococcal (therapy), Severity of Illness Index, Staphylococcal Infections (therapy), United States.
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents.
- geographic : Canada, Europe, United States.
- microbiology : Community-Acquired Infections, Pneumonia.
- therapy : Community-Acquired Infections, Pneumonia, Pneumonia, Pneumococcal, Staphylococcal Infections.
- Geography, Global Health, Guidelines as Topic, Humans, Methicillin-Resistant Staphylococcus aureus, Severity of Illness Index.
Abstract
Community-acquired pneumonia (CAP) is a common cause of morbidity and mortality worldwide, and since 1993, guidelines for management have been available. The process, which first began in the United States and Canada, has now been implemented in numerous countries throughout the world, and often each geographic region or country develops locally specific recommendations. It is interesting to realize that guidelines from different regions often interpret the same evidence base differently, and guidelines differ from one country to another, even though the bacteriology of CAP is often more similar than different from one region to another. One of the unique contributions of the 2007 US guidelines is the inclusion of quality and performance measures. In addition, US guidelines emphasize management principles that differ from some of the principles in European guidelines because of unique epidemiological considerations. In addition, certain therapy principles apply in the United States that differ from those in other regions, including the need for all patients to receive routine therapy for atypical pathogens, the emergence of community-acquired methicillin-resistant Staphylococcus aureus in some patients following influenza, and the need for all patients admitted to the intensive care unit to receive at least two antimicrobial agents. In the future, as guidelines evolve, there will be an important place for regional guidelines, particularly if these guidelines can recommend locally specific strategies to implement guidelines, which if successful, can lead to improved patient outcomes.
DOI: 10.1055/s-0032-1315642
PubMed: 22718216
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Community-acquired pneumonia guidelines: a global perspective.</title><author><name sortKey="Niederman, Michael S" sort="Niederman, Michael S" uniqKey="Niederman M" first="Michael S" last="Niederman">Michael S. Niederman</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Winthrop University Hospital, 222 Station Plaza N., Mineola, NY 11501, USA. mniederman@winthrop.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Winthrop University Hospital, 222 Station Plaza N., Mineola, NY 11501</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Luna, Carlos M" sort="Luna, Carlos M" uniqKey="Luna C" first="Carlos M" last="Luna">Carlos M. Luna</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22718216</idno><idno type="pmid">22718216</idno><idno type="doi">10.1055/s-0032-1315642</idno><idno type="wicri:Area/Main/Corpus">000430</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000430</idno><idno type="wicri:Area/Main/Curation">000430</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000430</idno><idno type="wicri:Area/Main/Exploration">000430</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Community-acquired pneumonia guidelines: a global perspective.</title><author><name sortKey="Niederman, Michael S" sort="Niederman, Michael S" uniqKey="Niederman M" first="Michael S" last="Niederman">Michael S. Niederman</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Winthrop University Hospital, 222 Station Plaza N., Mineola, NY 11501, USA. mniederman@winthrop.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Winthrop University Hospital, 222 Station Plaza N., Mineola, NY 11501</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Luna, Carlos M" sort="Luna, Carlos M" uniqKey="Luna C" first="Carlos M" last="Luna">Carlos M. Luna</name></author></analytic><series><title level="j">Seminars in respiratory and critical care medicine</title><idno type="eISSN">1098-9048</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (therapeutic use)</term><term>Canada</term><term>Community-Acquired Infections (microbiology)</term><term>Community-Acquired Infections (therapy)</term><term>Europe</term><term>Geography</term><term>Global Health</term><term>Guidelines as Topic</term><term>Humans</term><term>Methicillin-Resistant Staphylococcus aureus</term><term>Pneumonia (microbiology)</term><term>Pneumonia (therapy)</term><term>Pneumonia, Pneumococcal (therapy)</term><term>Severity of Illness Index</term><term>Staphylococcal Infections (therapy)</term><term>United States</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antibactériens (usage thérapeutique)</term><term>Canada</term><term>Europe</term><term>Géographie</term><term>Humains</term><term>Indice de gravité médicale</term><term>Infections communautaires ()</term><term>Infections communautaires (microbiologie)</term><term>Infections à staphylocoques ()</term><term>Pneumonie à pneumocoques ()</term><term>Pneumopathie infectieuse ()</term><term>Pneumopathie infectieuse (microbiologie)</term><term>Recommandations comme sujet</term><term>Santé mondiale</term><term>Staphylococcus aureus résistant à la méticilline</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term><term>Europe</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Infections communautaires</term><term>Pneumopathie infectieuse</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Community-Acquired Infections</term><term>Pneumonia</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Community-Acquired Infections</term><term>Pneumonia</term><term>Pneumonia, Pneumococcal</term><term>Staphylococcal Infections</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Geography</term><term>Global Health</term><term>Guidelines as Topic</term><term>Humans</term><term>Methicillin-Resistant Staphylococcus aureus</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Canada</term><term>Europe</term><term>Géographie</term><term>Humains</term><term>Indice de gravité médicale</term><term>Infections communautaires</term><term>Infections à staphylocoques</term><term>Pneumonie à pneumocoques</term><term>Pneumopathie infectieuse</term><term>Recommandations comme sujet</term><term>Santé mondiale</term><term>Staphylococcus aureus résistant à la méticilline</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Community-acquired pneumonia (CAP) is a common cause of morbidity and mortality worldwide, and since 1993, guidelines for management have been available. The process, which first began in the United States and Canada, has now been implemented in numerous countries throughout the world, and often each geographic region or country develops locally specific recommendations. It is interesting to realize that guidelines from different regions often interpret the same evidence base differently, and guidelines differ from one country to another, even though the bacteriology of CAP is often more similar than different from one region to another. One of the unique contributions of the 2007 US guidelines is the inclusion of quality and performance measures. In addition, US guidelines emphasize management principles that differ from some of the principles in European guidelines because of unique epidemiological considerations. In addition, certain therapy principles apply in the United States that differ from those in other regions, including the need for all patients to receive routine therapy for atypical pathogens, the emergence of community-acquired methicillin-resistant Staphylococcus aureus in some patients following influenza, and the need for all patients admitted to the intensive care unit to receive at least two antimicrobial agents. In the future, as guidelines evolve, there will be an important place for regional guidelines, particularly if these guidelines can recommend locally specific strategies to implement guidelines, which if successful, can lead to improved patient outcomes.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22718216</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-9048</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>3</Issue><PubDate><Year>2012</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Seminars in respiratory and critical care medicine</Title><ISOAbbreviation>Semin Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Community-acquired pneumonia guidelines: a global perspective.</ArticleTitle><Pagination><MedlinePgn>298-310</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0032-1315642</ELocationID><Abstract><AbstractText>Community-acquired pneumonia (CAP) is a common cause of morbidity and mortality worldwide, and since 1993, guidelines for management have been available. The process, which first began in the United States and Canada, has now been implemented in numerous countries throughout the world, and often each geographic region or country develops locally specific recommendations. It is interesting to realize that guidelines from different regions often interpret the same evidence base differently, and guidelines differ from one country to another, even though the bacteriology of CAP is often more similar than different from one region to another. One of the unique contributions of the 2007 US guidelines is the inclusion of quality and performance measures. In addition, US guidelines emphasize management principles that differ from some of the principles in European guidelines because of unique epidemiological considerations. In addition, certain therapy principles apply in the United States that differ from those in other regions, including the need for all patients to receive routine therapy for atypical pathogens, the emergence of community-acquired methicillin-resistant Staphylococcus aureus in some patients following influenza, and the need for all patients admitted to the intensive care unit to receive at least two antimicrobial agents. In the future, as guidelines evolve, there will be an important place for regional guidelines, particularly if these guidelines can recommend locally specific strategies to implement guidelines, which if successful, can lead to improved patient outcomes.</AbstractText><CopyrightInformation>Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Niederman</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Winthrop University Hospital, 222 Station Plaza N., Mineola, NY 11501, USA. mniederman@winthrop.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luna</LastName><ForeName>Carlos M</ForeName><Initials>CM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Semin Respir Crit Care Med</MedlineTA><NlmUniqueID>9431858</NlmUniqueID><ISSNLinking>1069-3424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005843" MajorTopicYN="N">Geography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017408" MajorTopicYN="Y">Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055624" MajorTopicYN="N">Methicillin-Resistant Staphylococcus aureus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011018" MajorTopicYN="N">Pneumonia, Pneumococcal</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22718216</ArticleId><ArticleId IdType="doi">10.1055/s-0032-1315642</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><noCountry><name sortKey="Luna, Carlos M" sort="Luna, Carlos M" uniqKey="Luna C" first="Carlos M" last="Luna">Carlos M. Luna</name></noCountry><country name="États-Unis"><region name="État de New York"><name sortKey="Niederman, Michael S" sort="Niederman, Michael S" uniqKey="Niederman M" first="Michael S" last="Niederman">Michael S. Niederman</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000454 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000454 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22718216
|texte= Community-acquired pneumonia guidelines: a global perspective.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22718216" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |